Other non-current Assets - Narrative (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) payment Payment	Mar. 31, 2022 USD ($)	Dec. 31, 2020 USD ($)	Jun. 30, 2020 USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Revenues	$ 11,134	$ 12,270
Number of guaranteed royalty payments | payment	8
License agreement with Sunovion Pharmaceuticals, Inc.
Acquired Finite-Lived Intangible Assets [Line Items]
Minimum annual royalty receivable	$ 1,000		$ 1,000
Number of annual royalty payments receivable | Payment	5
Royalty
Acquired Finite-Lived Intangible Assets [Line Items]
Revenues	$ (27)
Royalty | License agreement with Sunovion Pharmaceuticals, Inc.
Acquired Finite-Lived Intangible Assets [Line Items]
Revenues			$ 8,000	$ 8,000